Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease
03 mars 2017 15h39 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 3, 2017) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Publishes Promising Paper on Novel Treatment for Allergic Airway Disease
13 oct. 2016 20h31 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 13, 2016) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Closes Private Financing of CDN$4 Million
12 avr. 2016 11h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 12, 2016) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Awarded Genome BC Funding to Study QBECO Site Specific Immunomodulator (SSI) for Ulcerative Colitis
06 avr. 2016 10h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 6, 2016) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Announces Initial Results in Randomized, Placebo-Controlled Crohn's Disease Clinical Trial
21 mars 2016 08h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 21, 2016) - Qu Biologics Inc., an immunotherapy company developing Site Specific Immunomodulators (SSIs) for cancer and other inflammatory...
Qu Biologics Closes Oversubscribed Financing; Crohn's Disease Phase 2 Clinical Trial Results in First Quarter 2016
23 déc. 2015 09h05 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 23, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Completes Enrollment of Randomized Clinical Trial in Crohn's Disease
24 nov. 2015 08h20 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted Three New Patents for Treating Inflammatory Bowel Disease, Colon Cancer and Skin Cancer
17 nov. 2015 17h20 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 17, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted U.S. Patent for Use of Staphylococcus Aureus-Based Immunotherapies to Treat Melanoma
29 sept. 2015 09h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 29, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Opens Additional Ulcerative Colitis Clinical Trial Sites in Edmonton and Hamilton
31 août 2015 09h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...